BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GLB-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GLB-001\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06378437-3052@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:GLB-001: Phase 1 readout est. (NCT06378437)
DESCRIPTION:GLB-001\, phase 1\, Acute Myeloid Leukemia.\nStudy: A Study of 
 GLB-001 in Patients With Myeloid Malignancies\nEstimated primary completio
 n: 31 December 2026. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 glb-001#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT06378437
URL:https://assetmemo.bio/drug/glb-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
